NeuroBo Pharmaceuticals and Gemphire Therapeutics complete merger

This article was originally published here

The new combined company, known as NeuroBo Pharmaceuticals began trading on the Nasdaq exchange under the ticker “NRBO” on December 31, 2019. NeuroBo will focus on advancing the

The post NeuroBo Pharmaceuticals and Gemphire Therapeutics complete merger appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply